Anthony Welters
CIK: 0001213307
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Aug 26, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3.4K shares at avg. $148.24$504K - Aug 26, 2026GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct7.7K shares at avg. $60.67$468K - Aug 26, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct3.1K shares at avg. $148.31$462K - Aug 26, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct4.6K shares at avg. $148.82$685K - Aug 26, 2026GILD
GILEAD SCIENCES, INC.
Exercise(M)Direct10.3K shares at avg. $61.35$631K - Aug 26, 2026GILD
GILEAD SCIENCES, INC.
Sale(S)Direct6.9K shares at avg. $148.82$1.0M - May 1, 2026CG
Carlyle Group Inc.
Award(A)Direct4.5K shares- - Apr 30, 2026GILD
GILEAD SCIENCES, INC.
Award(A)Direct1.1K shares- - Nov 25, 2025CG
Carlyle Group Inc.
Gift(G)Direct1.2K shares- - Nov 25, 2025CG
Carlyle Group Inc.
Gift(G)Direct11.7K shares- - May 7, 2025GILD
GILEAD SCIENCES, INC.
Award(A)Direct1.5K shares- - May 1, 2025CG
Carlyle Group Inc.
Award(A)Direct5.2K shares- - Mar 3, 2025L
LOEWS CORP
Sale(S)Direct1.2K shares at avg. $86.87$104K - Mar 3, 2025L
LOEWS CORP
Disposition(D)Direct1.1K shares at avg. $86.89$91K - Mar 3, 2025L
LOEWS CORP
Exercise(M)Direct2.3K shares at avg. $40.61$91K - Dec 2, 2024L
LOEWS CORP
Sale(S)Direct1.1K shares at avg. $86.81$99K - Dec 2, 2024L
LOEWS CORP
Exercise(M)Direct2.3K shares at avg. $42.52$96K - Dec 2, 2024L
LOEWS CORP
Disposition(D)Direct1.1K shares at avg. $86.80$96K - Nov 27, 2024CG
Carlyle Group Inc.
Gift(G)Direct13.3K shares- - Sep 3, 2024L
LOEWS CORP
Exercise(M)Direct2.3K shares at avg. $41.98$94K - Sep 3, 2024L
LOEWS CORP
Disposition(D)Direct1.2K shares at avg. $81.42$95K - Sep 3, 2024L
LOEWS CORP
Sale(S)Direct1.1K shares at avg. $81.41$89K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 26, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,402 | $148.24 | $504,296 | Direct |
| Aug 26, 2026 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 7,718 | $60.67 | $468,251 | Direct |
| Aug 26, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 3,118 | $148.31 | $462,432 | Direct |
| Aug 26, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 4,600 | $148.82 | $684,590 | Direct |
| Aug 26, 2026 | GILD GILEAD SCIENCES, INC. | Exercise(M) | 10,282 | $61.35 | $630,801 | Direct |
| Aug 26, 2026 | GILD GILEAD SCIENCES, INC. | Sale(S) | 6,880 | $148.82 | $1,023,900 | Direct |
| May 1, 2026 | CG Carlyle Group Inc. | Award(A) | 4,450 | - | $0 | Direct |
| Apr 30, 2026 | GILD GILEAD SCIENCES, INC. | Award(A) | 1,146 | - | $0 | Direct |
| Nov 25, 2025 | CG Carlyle Group Inc. | Gift(G) | 1,200 | - | - | Direct |
| Nov 25, 2025 | CG Carlyle Group Inc. | Gift(G) | 11,706 | - | - | Direct |
| May 7, 2025 | GILD GILEAD SCIENCES, INC. | Award(A) | 1,516 | - | - | Direct |
| May 1, 2025 | CG Carlyle Group Inc. | Award(A) | 5,235 | - | - | Direct |
| Mar 3, 2025 | L LOEWS CORP | Sale(S) | 1,197 | $86.87 | $103,983 | Direct |
| Mar 3, 2025 | L LOEWS CORP | Disposition(D) | 1,053 | $86.89 | $91,495 | Direct |
| Mar 3, 2025 | L LOEWS CORP | Exercise(M) | 2,250 | $40.61 | $91,373 | Direct |
| Dec 2, 2024 | L LOEWS CORP | Sale(S) | 1,146 | $86.81 | $99,484 | Direct |
| Dec 2, 2024 | L LOEWS CORP | Exercise(M) | 2,250 | $42.52 | $95,670 | Direct |
| Dec 2, 2024 | L LOEWS CORP | Disposition(D) | 1,104 | $86.80 | $95,827 | Direct |
| Nov 27, 2024 | CG Carlyle Group Inc. | Gift(G) | 13,280 | - | $0 | Direct |
| Sep 3, 2024 | L LOEWS CORP | Exercise(M) | 2,250 | $41.98 | $94,455 | Direct |
| Sep 3, 2024 | L LOEWS CORP | Disposition(D) | 1,162 | $81.42 | $94,610 | Direct |
| Sep 3, 2024 | L LOEWS CORP | Sale(S) | 1,088 | $81.41 | $88,574 | Direct |
1-22 of 22 transactions
About WELTERS ANTHONY
WELTERS ANTHONY (SEC CIK 0001213307) files insider reports with the SEC as Director of GILEAD SCIENCES, INC. (GILD), Director of Carlyle Group Inc. (CG) and Director of LOEWS CORP (L).
Signal8 holds 10 ownership filings by WELTERS ANTHONY, all Form 4s, filed between Sep 4, 2024 and Aug 27, 2026. Those filings report 22 transactions, from Sep 3, 2024 to Aug 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WELTERS ANTHONY's filings is in FOSTER CITY, CA.
Recent filings by WELTERS ANTHONY
- Aug 26, 2026: Open-market sale of GILD shares (Form 4, code S).
- Aug 26, 2026: Option exercise of GILD shares (Form 4, code M).
- Aug 26, 2026: Open-market sales of GILD shares (2 lines, Form 4, code S).
- Aug 26, 2026: Option exercise of GILD shares (Form 4, code M).
- Aug 26, 2026: Open-market sale of GILD shares (Form 4, code S).
Other insiders filing for GILEAD SCIENCES, INC. (GILD)
- O'Day Daniel Patrick, Chairman & CEO
- Dickinson Andrew D, Chief Financial Officer
- Mercier Johanna, Chief Comm & Corp Aff Officer
- Burkhart Erin, SVP, Controllership
- Berger Dietmar, Chief Medical Officer
- Cain Wettan Keeley M, EVP Gen Counsel, Legal & Comp